We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $111M
1-Year Est. Return 74.4%
This Fund
S&P 500
This Quarter Est. Return
-24.42%
1 Year Est. Return
-74.4%
3 Year Est. Return
-95.55%
5 Year Est. Return
-99.44%
10 Year Est. Return
-99.5%
AUM
$137M
AUM Growth
+$14.4M
Cap. Flow
+$30.3M
Cap. Flow %
22.19%
Top 10 Hldgs %
90.6%
Holding
116
New
26
Increased
16
Reduced
32
Closed
31

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$13.7M
2
SEEL
Seelos Therapeutics, Inc. Common Stock
SEEL
+$13.2M
3
EZGO
EZGO Technologies
EZGO
+$4.47M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$2.67M
5
DUO
Fangdd Network Group
DUO
+$2.19M

Top Sells

Rank Stock Value
1
BCLI
BRAINSTORM CELL THERAPUTC
BCLI
+$1.71M
2
SONN
Sonnet BioTherapeutics
SONN
+$1.61M
3
SIDU icon
Sidus Space
SIDU
+$1.16M
4
ITRM
Iterum Therapeutics
ITRM
+$1.13M
5
AKTX
Akari Therapeutics
AKTX
+$741K

Sector Composition

Rank Sector Weight
1 Miscellaneous 88.59%
2 Healthcare 7.31%
3 Consumer Discretionary 1.12%
4 Communication Services 0.83%
5 Energy 0.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TIO
76
PUT
DELISTED
Tingo Group, Inc. Common Stock
TIO
$15.2K 0.01%
+148
New +$187
LUCYW icon
77
Innovative Eyewear Inc Series A Warrants 8/16/27
LUCYW
$13.5K 0.01%
104,535
– –
OPTT icon
78
Ocean Power Technologies
OPTT
$18.5M
$10.4K 0.01%
887
– –
MMAT
79
PUT
DELISTED
Meta Materials Inc. Common Stock
MMAT
$10K 0.01%
+5
New +$109
ARQQ icon
80
Arqit Quantum
ARQQ
$318M
$8.12K 0.01%
+546
New +$13.3K
CISS
81
C3is
CISS
$1.86M
– –
0
– –
NEXRW
82
Nexera Technologies Ltd Warrant
NEXRW
$80.4K
$2.71K ﹤0.01%
77,282
– –
BCLI
83
PUT
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$2.12K ﹤0.01%
7
– –
ADTX
84
DELISTED
ADITXT INC
ADTX
– –
0
– -$265K
ANY icon
85
PUT
Sphere 3D
ANY
$24.2M
– –
-84
Closed -$105K
ASTI icon
86
Ascent Solar Technologies
ASTI
$27.1M
– –
-29
Closed -$71.8K
BBIO icon
87
CALL
BridgeBio Pharma
BBIO
$13.4B
– –
-194
Closed -$334K
BBLG
88
Bone Biologics
BBLG
$1.49M
– –
-225
Closed -$15.5K
BEATW icon
89
Heartbeam Inc Warrant
BEATW
$22K
– –
-17,908
Closed -$7.16K
CNEY icon
90
CN Energy Group
CNEY
$4.43M
– –
-291
Closed -$44K
COSM icon
91
Cosmos Holdings
COSM
$27.9M
– –
-35,006
Closed -$105K
EDBL
92
Edible Garden
EDBL
$2.75M
– –
-1
Closed -$158K
GLBS icon
93
Globus Maritime Ltd
GLBS
$77.7M
– –
-411,907
Closed -$370K
GLBS icon
94
PUT
Globus Maritime Ltd
GLBS
$77.7M
– –
-529
Closed -$47.5K
IBIO icon
95
PUT
iBio
IBIO
$76.5M
– –
-149
Closed -$181K
IMPP icon
96
PUT
Imperial Petroleum
IMPP
$263M
– –
-795
Closed -$245K
ITRM
97
DELISTED
Iterum Therapeutics
ITRM
– –
-75,000
Closed -$1.13M
KPRX icon
98
Kiora Pharmaceuticals
KPRX
$11.5M
– –
-34,708
Closed -$201K
SVRN
99
SVRN, Inc. Common Stock
SVRN
$20.8M
– –
-238
Closed -$195K
SHFS icon
100
SHF Holdings
SHFS
$1.79M
– –
-63,139
Closed -$669K
1 2 3
4
5

Similar funds

IWA
Independent Wealth Advisors Cary, North Carolina $111M AUM
BFA
Ballast Financial Advisors West Chester, Pennsylvania $110M AUM
WPWM
Western Pacific Wealth Management Lake Forest, Illinois $111M AUM 26.64% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
ZS
Zenith Solutions Philadelphia, Pennsylvania $110M AUM
KC
Karras Company Roy, Utah $110M AUM
FI
FinArc Investments Norwood, Massachusetts $110M AUM
CIM
Catalyst Investment Management Windham, New Hampshire $110M AUM

Sabby Management's Q3 2023 Portfolio in Review

As of Q3 2023, Sabby Management held 116 positions worth $137M, up 12% from $122M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Sabby Management deployed $30.3M of net new capital in Q3 2023, opening 26 new positions and adding to 16 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 73,000 shares worth $12.9M.

By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, up from 77% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was BRAINSTORM CELL THERAPUTC, an estimated $1.71M trimmed.

  • Sabby Management's largest Q3 2023 buy was iShares Russell 2000 ETF: 73,000 shares worth $12.9M.
  • Sabby Management added most to Neptune Wellness Solutions Inc. Ordinary Shares in Q3 2023, an estimated $799K increase.
  • Sabby Management's biggest Q3 2023 reduction was BRAINSTORM CELL THERAPUTC, cutting an estimated $1.71M.
  • Sabby Management fully exited Sonnet BioTherapeutics in Q3 2023, selling an estimated $1.61M.
  • Sabby Management's ten largest holdings make up 91% of its $137M portfolio in Q3 2023.
  • Sabby Management opened 26 new positions and closed 31 in Q3 2023.
  • Sabby Management's portfolio value rose 12% quarter-over-quarter to $137M.

Based on Sabby Management's 13F filing for Q3 2023, filed 14 Nov 2023.